National Institutes of Health – Applying Metabolomics to Drive Biomarker Discovery in Symptom Science

The purpose of this funding opportunity announcement is to encourage applications on biomarker discovery that utilize metabolomics approaches to advance the understanding, assessment and management of symptoms.

Award amount:

The combined budget for direct costs for the two year project period may not exceed $275 000. No more than $200 000 in direct costs may be requested in any single year.

Non-U.S. entities are eligible to apply.

Deadline for applications 07 September 2018

More information can be found at: